{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:42:48Z","timestamp":1762850568482,"version":"build-2065373602"},"reference-count":20,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15300","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:33:30Z","timestamp":1758803610000},"page":"1-5","source":"Crossref","is-referenced-by-count":0,"title":["Transarterial infusion chemotherapy for severe hepatic dysfunction and poor performance status in diffuse hepatic metastasis: A case report"],"prefix":"10.3892","volume":"30","author":[{"given":"Xiao-Chun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Oncology, The First People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Qin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ping","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"key20251111103818_b1-ol-30-6-15300","first-page":"1477","article-title":"Incidence and prognosis of liver metastasis at diagnosis: A pan-cancer population-based study","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"key20251111103818_b2-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000335597","article-title":"ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary","volume":"95","author":"Pavel","year":"2012","journal-title":"Neuroendocrinology"},{"key":"key20251111103818_b3-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/hep.25950","article-title":"Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona clinic liver cancer system","volume":"57","author":"Hsu","year":"2013","journal-title":"Hepatology"},{"key":"key20251111103818_b4-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1200\/JCO.2002.04.019","article-title":"Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site","volume":"20","author":"Culine","year":"2002","journal-title":"J Clin Oncol"},{"key":"key20251111103818_b5-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"key20251111103818_b6-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cgh.2017.04.042","article-title":"Multicenter external validation of risk stratification criteria for patients with variceal bleeding","volume":"16","author":"Conejo","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20251111103818_b7-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/gutjnl-2023-331695","article-title":"British society of gastroenterology guidelines for the management of hepatocellular carcinoma in adults","volume":"73","author":"Suddle","year":"2024","journal-title":"Gut"},{"key":"key20251111103818_b8-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"key20251111103818_b9-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41585-024-00875-x","article-title":"From biology to the clinic-exploring liver metastasis in prostate cancer","volume":"21","author":"Ni","year":"2024","journal-title":"Nat Rev Urol"},{"key":"key20251111103818_b10-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: A multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J Clin Oncol"},{"key":"key20251111103818_b11-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20251111103818_b12-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00000478-200606000-00005","article-title":"Small cell carcinoma of the prostate: An immunohistochemical study","volume":"30","author":"Yao","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"key20251111103818_b13-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1158\/1078-0432.CCR-12-3791","article-title":"Platinum-based chemotherapy for variant castrate-resistant prostate cancer","volume":"19","author":"Aparicio","year":"2013","journal-title":"Clin Cancer Res"},{"key":"key20251111103818_b14-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/bju.15086","article-title":"Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer","volume":"127","author":"Szarvas","year":"2021","journal-title":"BJU Int"},{"key":"key20251111103818_b15-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1158\/1078-0432.CCR-24-2061","article-title":"Framework for the pathology workup of metastatic castration-resistant prostate cancer biopsies","volume":"31","author":"Haffner","year":"2025","journal-title":"Clin Cancer Res"},{"key":"key20251111103818_b16-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"102274","DOI":"10.1016\/j.clgc.2024.102274","article-title":"Real-world clinical outcomes and prognostic factors in neuroendocrine prostate cancer","volume":"23","author":"Gagnon","year":"2025","journal-title":"Clin Genitourin Cancer"},{"key":"key20251111103818_b17-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2022.05.007","article-title":"Molecular mechanisms underlying the development of neuroendocrine prostate cancer","volume":"86","author":"Liu","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"key20251111103818_b18-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3348\/kjr.2015.16.6.1283","article-title":"The safety and clinical outcomes of chemoembolization in child-pugh class C patients with hepatocellular carcinomas","volume":"16","author":"Choi","year":"2015","journal-title":"Korean J Radiol"},{"key":"key20251111103818_b19-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1159\/000501548","article-title":"Small-Cell lung cancer treatment of newly diagnosed patients with poor performance status","volume":"12","author":"Aida","year":"2019","journal-title":"Case Rep Oncol"},{"key":"key20251111103818_b20-ol-30-6-15300","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1080\/0284186X.2019.1637934","article-title":"Outcome of treatment in patients with small cell lung cancer in poor performance status","volume":"58","author":"Bahij","year":"2019","journal-title":"Acta Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T08:38:22Z","timestamp":1762850302000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,9,25]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15300","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"type":"print","value":"1792-1074"},{"type":"electronic","value":"1792-1082"}],"subject":[],"published":{"date-parts":[[2025,9,25]]}}}